MSN Laboratories, a private drug manufacturing company, launched two new pain killer drugs known as Tapal and Febuday through Pharmamed, a Lilongwe based pharmaceutical company at a ceremony held at Lilongwe Hotel in Lilongwe. The was patrionised by medical doctors, pharmacists from private and public hospitals and various other stakeholders.
Speaking during the launch, Dr Edgar Kuchingale who is also a Consultant Obstetrician/Gynecologist at Medical Aid Society of Malawi (MASM) commended MSN Laboratories for bringing the new drugs into Malawi. He said the launching of the new drugs was both an achievement to the country and to MSN as a company. “This is an achievement to both the country and to MSN as a company that is bringing in the new drugs into Malawi,” said Kuchingale.
He urged MSN to keep it up and to always remember Malawi pharmacies when there are new drugs on the market. Commenting on the development to the Malawi News Agency (Mana), Pharmamed Medical Sales Representatives Elias Daimoni said Tapal is amongst the strongest pain killers available while Febuday helps in controlling pain on people with gout, hyperuracemia and other severe pain related diseases.
He further confirmed of another launching ceremony in the Southern region on Friday. “Today MSN through Pharmamed was launching Tapal and Febuday in Lilongwe and on Friday there will be another launching ceremony in Blantyre,” said Daimoni. He said the new drugs which are in tablet form are expected to be in injection by the year 2016.